• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives.沙特阿拉伯糖尿病患者中的 COVID-19：现状与新视角。
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102231. doi: 10.1016/j.dsx.2021.102231. Epub 2021 Jul 24.
2
COVID-19 in People with Diabetes: Perspectives from Saudi Arabia.沙特阿拉伯视角下的糖尿病患者中的 COVID-19 问题。
Curr Diabetes Rev. 2021;17(6):e111020187810. doi: 10.2174/1573399816999201110195222.
3
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
4
Public acceptance of COVID-19 vaccination among residents of Saudi Arabia: a cross-sectional online study.沙特阿拉伯居民对 COVID-19 疫苗接种的公众接受度：一项横断面在线研究。
BMJ Open. 2022 Oct 31;12(10):e058180. doi: 10.1136/bmjopen-2021-058180.
5
Acceptance and barriers of COVID-19 vaccination among people with chronic diseases in Saudi Arabia.沙特阿拉伯慢性病患者对 COVID-19 疫苗接种的接受程度和障碍。
J Infect Dev Ctries. 2021 Nov 30;15(11):1646-1652. doi: 10.3855/jidc.15063.
6
COVID-19 vaccine hesitancy among patients with diabetes in Saudi Arabia.沙特阿拉伯糖尿病患者对 COVID-19 疫苗的犹豫。
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102271. doi: 10.1016/j.dsx.2021.102271. Epub 2021 Sep 4.
7
Assessment of caregivers' perspectives regarding speech-language services in Saudi Arabia during COVID-19.评估在 COVID-19 期间，沙特阿拉伯的照顾者对言语语言服务的看法。
PLoS One. 2021 Jun 22;16(6):e0253441. doi: 10.1371/journal.pone.0253441. eCollection 2021.
8
Spatial Analysis of COVID-19 Vaccine Centers Distribution: A Case Study of the City of Jeddah, Saudi Arabia.新冠疫苗接种中心分布的空间分析：以沙特阿拉伯吉达市为例
Int J Environ Res Public Health. 2022 Mar 16;19(6):3526. doi: 10.3390/ijerph19063526.
9
Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the "Mix-and-Match" Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey.沙特阿拉伯民众对不同类型 COVID-19 疫苗、“混打”策略的认知和接受度：基于网络的横断面调查。
Int J Environ Res Public Health. 2022 Oct 26;19(21):13889. doi: 10.3390/ijerph192113889.
10
Willingness to receive COVID-19 vaccination among adults with chronic diseases in the Kingdom of Saudi Arabia.沙特阿拉伯王国慢性病成年人对 COVID-19 疫苗接种的意愿。
J Infect Public Health. 2021 Oct;14(10):1489-1496. doi: 10.1016/j.jiph.2021.08.002. Epub 2021 Aug 13.

引用本文的文献

1
Dyslipidemia Associated With Type 2 Diabetes Mellitus as a Strong Predictor of ICU Admission in COVID-19 Patients: A Retrospective Comparative Study.2型糖尿病相关血脂异常作为COVID-19患者入住重症监护病房的强预测因素：一项回顾性比较研究
Cureus. 2025 Jul 2;17(7):e87193. doi: 10.7759/cureus.87193. eCollection 2025 Jul.
2
Changes in screening, diagnosis, management, and outcomes of gestational diabetes during the COVID-19 pandemic: A systematic review.2019年冠状病毒病大流行期间妊娠期糖尿病的筛查、诊断、管理及结局变化：一项系统评价
Heliyon. 2024 May 25;10(11):e31943. doi: 10.1016/j.heliyon.2024.e31943. eCollection 2024 Jun 15.
3
Prediction of in-hospital mortality rate in COVID-19 patients with diabetes mellitus using machine learning methods.使用机器学习方法预测2型糖尿病合并新型冠状病毒肺炎患者的院内死亡率
J Diabetes Metab Disord. 2023 May 13;22(2):1-14. doi: 10.1007/s40200-023-01228-y.
4
The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study.BNT162b2、ChAdOx1-S 和 mRNA-1273 疫苗及其两种加强针的结果：一项前瞻性纵向真实世界研究。
Viruses. 2023 Jan 24;15(2):326. doi: 10.3390/v15020326.
5
A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes.《药物基因组学和代谢组学对二甲双胍治疗 2 型糖尿病疗效影响的研究综述》
Int J Med Sci. 2023 Jan 1;20(1):142-150. doi: 10.7150/ijms.77206. eCollection 2023.
6
COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management.2019冠状病毒病与糖尿病：从病理生理学到临床管理
Cureus. 2022 Nov 25;14(11):e31895. doi: 10.7759/cureus.31895. eCollection 2022 Nov.
7
Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.中东人群中 COVID-19 的预后：已知与未知
Front Microbiol. 2022 Aug 31;13:974205. doi: 10.3389/fmicb.2022.974205. eCollection 2022.
8
Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry.沙特阿拉伯糖尿病患者中新冠病毒感染的患病率及其疫苗接种覆盖情况：基于医院糖尿病登记处的横断面分析
Vaccines (Basel). 2022 Feb 16;10(2):310. doi: 10.3390/vaccines10020310.
9
Digital Health Platforms in Saudi Arabia: Determinants from the COVID-19 Pandemic Experience.沙特阿拉伯的数字健康平台：来自新冠疫情经历的决定因素
Healthcare (Basel). 2021 Nov 8;9(11):1517. doi: 10.3390/healthcare9111517.

本文引用的文献

1
Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia.沙特阿拉伯新冠疫苗相关副作用评估
Vaccines (Basel). 2021 Jun 18;9(6):674. doi: 10.3390/vaccines9060674.
2
Launching COVID-19 vaccination in Saudi Arabia: Lessons learned, and the way forward.在沙特阿拉伯启动 COVID-19 疫苗接种：经验教训和未来方向。
Travel Med Infect Dis. 2021 Sep-Oct;43:102119. doi: 10.1016/j.tmaid.2021.102119. Epub 2021 Jun 13.
3
Clinical and demographic characteristics of patients with coronavirus disease 2019 in Security Forces Hospital, Riyadh, Saudi Arabia.沙特阿拉伯利雅得安全部队医院2019冠状病毒病患者的临床和人口统计学特征。
J Family Med Prim Care. 2021 Feb;10(2):947-952. doi: 10.4103/jfmpc.jfmpc_1484_20. Epub 2021 Feb 27.
4
A comprehensive review and update on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus disease 2019 (COVID-19): what do we know now in 2021?关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）和2019冠状病毒病（COVID-19）的全面综述与更新：2021年我们现在了解了什么？
Arch Med Sci Atheroscler Dis. 2021 Apr 6;6:e5-e13. doi: 10.5114/amsad.2021.105065. eCollection 2021.
5
Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia.沙特阿拉伯一家医院中不同年龄组确诊 2019 年冠状病毒病（COVID-19）患者的流行病学、临床和实验室结果。
PLoS One. 2021 Apr 29;16(4):e0250955. doi: 10.1371/journal.pone.0250955. eCollection 2021.
6
The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children.新冠疫情封锁对沙特儿童新发 1 型糖尿病和酮症酸中毒发病率的影响。
Front Endocrinol (Lausanne). 2021 Apr 1;12:669302. doi: 10.3389/fendo.2021.669302. eCollection 2021.
7
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review.2 型糖尿病与 COVID-19：叙事性综述。
Front Endocrinol (Lausanne). 2021 Mar 31;12:609470. doi: 10.3389/fendo.2021.609470. eCollection 2021.
8
Diabetes and COVID-19.糖尿病与2019冠状病毒病
Open Life Sci. 2021 Mar 25;16(1):297-302. doi: 10.1515/biol-2021-0034. eCollection 2021.
9
Newly diagnosed diabetes in patients with mild to moderate COVID-19.COVID-19 轻症和中度患者新发糖尿病。
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):569-571. doi: 10.1016/j.dsx.2021.02.034. Epub 2021 Mar 3.
10
Predictors of Hospitalization Among Older Adults with COVID-19 in Saudi Arabia: A Cross-Sectional Study of a Nationally Representative Sample.沙特阿拉伯新冠肺炎老年患者住院的预测因素：一项全国代表性样本的横断面研究
Risk Manag Healthc Policy. 2021 Mar 3;14:875-886. doi: 10.2147/RMHP.S294786. eCollection 2021.

沙特阿拉伯糖尿病患者中的 COVID-19：现状与新视角。

COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives.

机构信息

Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

出版信息

Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102231. doi: 10.1016/j.dsx.2021.102231. Epub 2021 Jul 24.

DOI:10.1016/j.dsx.2021.102231
PMID:34330072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8302829/
Abstract

BACKGROUND AND AIM

This review aims to report the current status of COVID-19 among people with diabetes, newly diagnosed diabetes, diabetic ketoacidosis, and programmatic efforts including vaccinations.

METHODS

We conducted a literature search using PubMed, Google, and Scopus until July 15, 2021.

RESULTS

In Saudi Arabia, most studies have reported diabetes as one of the highly prevalent comorbidities among patients with COVID-19. Currently, there are limited studies from Saudi Arabia on the newly diagnosed diabetes and diabetic ketoacidosis caused by COVID-19. The Saudi ministry has taken several measures to control the impact of COVID-19 among people with diabetes, including comprehensive guidelines and prioritized vaccinations. During the COVID-19 pandemic, the use of telehealth services dramatically increased in diabetes clinics in Saudi Arabia.

CONCLUSIONS

Focused and evidence-based interventions are essential to control the impact of COVID-19 among people with diabetes.

摘要

背景与目的

本综述旨在报告 COVID-19 在糖尿病患者、新诊断糖尿病患者、糖尿病酮症酸中毒患者中的现状，以及包括疫苗接种在内的规划工作。

方法

我们使用 PubMed、Google 和 Scopus 进行了文献检索，检索截至 2021 年 7 月 15 日。

结果

在沙特阿拉伯，大多数研究报告称，糖尿病是 COVID-19 患者中高发的合并症之一。目前，沙特阿拉伯关于 COVID-19 导致的新诊断糖尿病和糖尿病酮症酸中毒的研究有限。沙特政府已采取多项措施来控制 COVID-19 对糖尿病患者的影响，包括制定综合指南和优先接种疫苗。在 COVID-19 大流行期间，沙特阿拉伯的糖尿病诊所大量使用远程医疗服务。

结论

需要有针对性和基于证据的干预措施来控制 COVID-19 对糖尿病患者的影响。